Zyrop 10000 Injection belongs to the group of hormones used in the treatment of chronic anaemia and anaemic states seen in kidney disease, cancers, patients on chemotherapy, bone marrow disorders, and those due to undergo major bone surgery. Anaemia refers to low blood counts due to a deficiency of the blood component haemoglobin, resulting in a reduced oxygen-carrying capacity of the blood. Zyrop 10000 Injection contains Recombinant Human Erythropoietin Alfa, which works by stimulating the bone marrow to produce more red blood cells, thereby correcting low blood counts and anaemia. In some cases, Zyrop 10000 Injection may cause specific common side effects such as vomiting, diarrhoea, fever, and nasal congestion. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to talk to your doctor if you experience these side effects consistently. Please inform the doctor of your detailed medical history, including hypertension, heart disease, heart attack, stroke, epilepsy, cancer, liver disease, thromboembolism, porphyria and/or pure red cell aplasia (where the bone marrow cannot produce enough RBCs). Consult your doctor before taking Zyrop 10000 Injection during pregnancy and nursing. Store this medicine at 2°C-8°C. Do not freeze.

Zyrop 5000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Zyrop 5000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Zyrop 5000IU injection.

Eporise 10000 Injection belongs to the group of hormones used in the treatment of chronic anaemia and anaemic states seen in kidney disease, cancers, patients on chemotherapy, bone marrow disorders, and those due to undergo major bone surgery. Anaemia refers to low blood counts due to a deficiency of the blood component haemoglobin, resulting in a reduced oxygen-carrying capacity of the blood. Eporise 10000 Injection contains Recombinant Human Erythropoietin Alfa, which works by stimulating the bone marrow to produce more red blood cells, thereby correcting low blood counts and anaemia. In some cases, Eporise 10000 Injection may cause specific common side effects such as vomiting, diarrhoea, fever, and nasal congestion. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to talk to your doctor if you experience these side effects consistently. Please inform the doctor of your detailed medical history, including hypertension, heart disease, heart attack, stroke, epilepsy, cancer, liver disease, thromboembolism, porphyria and/or pure red cell aplasia (where the bone marrow cannot produce enough RBCs). Consult your doctor before taking Eporise 10000 Injection during pregnancy and nursing. Store this medicine at 2°C-8°C. Do not freeze.

DARCEPT 40MG INJECTION belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). DARCEPT 40MG INJECTION helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. DARCEPT 40MG INJECTION contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. DARCEPT 40MG INJECTION is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, DARCEPT 40MG INJECTION stimulates the production of this protein in the bone marrow. DARCEPT 40MG INJECTION will be injected by the healthcare provider. Do not self-administer. The most common side effects of DARCEPT 40MG INJECTION are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of DARCEPT 40MG INJECTION do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Zynesp 200 mcg Injection belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). Zynesp 200 mcg Injection helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. Zynesp 200 mcg Injection contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. Zynesp 200 mcg Injection is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, Zynesp 200 mcg Injection stimulates the production of this protein in the bone marrow. Zynesp 200 mcg Injection will be injected by the healthcare provider. Do not self-administer. The most common side effects of Zynesp 200 mcg Injection are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of Zynesp 200 mcg Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor. If you have uncontrolled/untreated high blood pressure or red cell aplasia (a type of anaemia) due to darbepoetin alfa or epoetin alfa, please inform your doctor before taking Zynesp 200 mcg Injection to avoid any complications. Also, mention all the other medications you are taking to affect the way Zynesp 200 mcg Injection works. Inform your doctor immediately, if you feel weak, lightheaded, tired, or short of breath, or if your skin looks pale as it may be signs that the body has stopped responding to Zynesp 200 mcg Injection .

Oxemia 100 Tablet is a medicine used in the treatment of anemia due to chronic kidney disease. It works by stimulating erythropoietin (a hormone secreted by the kidneys) leading to an increase in the production of red blood cells. It is important that you seek Oxemia 100 Tablet treatment from a doctor who is experienced in providing this medical therapy. It is given under the supervision of a healthcare professional and you should follow all the directions of the doctor strictly. Oxemia 100 Tablet is a medicine that needs to be used with utmost care because it can lead to side effects. It may cause side effects like abdominal pain, vomiting, headache, fever, weakness, and peripheral edema. If you notice these side effects or do not resolve, please inform the doctor. If you notice severe side effects, please inform the doctor. The doctor may suggest ways to treat or prevent any such side effects from occurring again.

Oxemia 50 Tablet is a medicine used in the treatment of anemia due to chronic kidney disease. It works by stimulating erythropoietin (a hormone secreted by the kidneys) leading to an increase in the production of red blood cells. It is important that you seek Oxemia 50 Tablet treatment from a doctor who is experienced in providing this medical therapy. It is given under the supervision of a healthcare professional and you should follow all the directions of the doctor strictly. Oxemia 50 Tablet is a medicine that needs to be used with utmost care because it can lead to side effects. It may cause side effects like abdominal pain, vomiting, headache, fever, weakness, and peripheral edema. If you notice these side effects or do not resolve, please inform the doctor. If you notice severe side effects, please inform the doctor. The doctor may suggest ways to treat or prevent any such side effects from occurring again.

Erypro safe 4000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Erypro safe 4000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Erypro safe 4000IU injection.

Primary Uses: Anemia due to Chronic Kidney Disease (CKD): In CKD, the kidneys produce less erythropoietin, leading to decreased red blood cell production. Actorise 100 Injection helps stimulate the bone marrow to produce more red blood cells, thereby improving oxygen delivery and reducing symptoms like fatigue and weakness.​ Anemia due to Cancer Chemotherapy: Chemotherapy can suppress bone marrow function, leading to decreased red blood cell production. Actorise 100 Injection helps stimulate red blood cell production, mitigating anemia and its associated symptoms in cancer patients undergoing chemotherapy.​ 💉 How It Works: Darbepoetin alfa is a synthetic form of erythropoietin. By binding to erythropoietin receptors in the bone marrow, it promotes the proliferation and differentiation of red blood cell precursors, leading to increased red blood cell production.​